VCAN Hypomethylation and Expression as Predictive Biomarkers of Drug Sensitivity in Upper Urinary Tract Urothelial Carcinoma

Versican (VCAN), also known as extracellular matrix proteoglycan 2, has been suggested as a potential biomarker in cancers. Previous research has found that VCAN is highly expressed in bladder cancer. However, its role in predicting outcomes for patients with upper urinary tract urothelial cancer (U...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Hao-Lun, Chang, Yin-Lun, Liu, Hui-Ying, Wu, Yen-Ting, Sung, Ming-Tse, Su, Yu-Li, Huang, Chun-Chieh, Wang, Pei-Chia, Peng, Jei-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10139123/
https://www.ncbi.nlm.nih.gov/pubmed/37108649
http://dx.doi.org/10.3390/ijms24087486

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10139123/
https://www.ncbi.nlm.nih.gov/pubmed/37108649
http://dx.doi.org/10.3390/ijms24087486

Ejemplares similares